Zeo ScientifiX (ZEOX) Stock Price & Analysis

ZEOX Stock Chart & Stats

$1.36$0.00(0.00%)

At close: Oct 30 4:00 PM EDT

Day’s Range: $1.25 - $1.37
52-Week Range: $0.84 - $2.99
Previous Close: $1.36
Volume: 200
Average Volume (3M): 9,436
Market Cap: $10.66M
Enterprise Value: $9.31T
Total Cash (Recent Filing): $1.85M
Total Debt (Recent Filing): $96.00K
Price to Earnings (P/E): ―
Beta: 0.69
Next Earnings: N/A
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Zeo ScientifiX News

Zeo ScientifiX licenses Pluri tech, restructures ownership

Zeo ScientifiX ( ($ZEOX) ) just unveiled an update. On October 26, 2026, Zeo ScientifiX and Pluri Inc. entered into a strategic license-for-equity partnership to expand U.S. manufacturing and commercialization

3d ago8K ZEOX

Zeo ScientifiX, Pluri forge strategic regenerative medicine pact

An update from Zeo ScientifiX ( ($ZEOX) ) is now available. On October 26, 2026, ZEO ScientifiX and Pluri Inc. announced a definitive strategic agreement to expand their U.S. manufacturing

1w ago8K ZEOX

Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform

Haifa, Israel, October 26th, 2026, FinanceWire Pluri and ZEO ScientifiX Partner to Expand U.S. Manufacturing and Commercial Platform for Regenerative Medicine. Partnership combines Pluri’s proprietary cell technology and clinical-development experience

1w agoPLUR ZEOX

Zeo ScientifiX Delays Transition Annual Filing

Zeo ScientifiX ( ($ZEOX) ) has released a notification of late filing. Zeo ScientifiX, Inc. has filed a Form 12b-25, notifying investors that it will be late in filing its

1M agoZEOX

Zeo ScientifiX Announces Change in Fiscal Year End

Zeo ScientifiX ( ($ZEOX) ) has issued an update. Zeo ScientifiX changed its fiscal year end from October 31 to June 30, a decision approved by its Board of Directors

1M ago8K ZEOX

Zeo ScientifiX Expands Regenerative Medicine Operations in Southeast

Zeo ScientifiX ( ($ZEOX) ) has provided an announcement. On September 15, 2026, ZEO ScientifiX, Inc., a clinical-stage biopharmaceutical company specializing in regenerative biologics and physician education, announced plans to

1M ago8K ZEOX

Zeo ScientifiX Delays Quarterly SEC Filing

Zeo ScientifiX ( ($ZEOX) ) has released a notification of late filing. Zeo ScientifiX, Inc. has notified investors that it will delay filing its Form 10-Q (Quarter Report) for the

1M agoZEOX

ZEO ScientifiX Unveils Inaugural Regenerative Medicine Xperience

Zeo ScientifiX ( ($ZEOX) ) just unveiled an announcement. On September 1, 2026, ZEO ScientifiX announced the multidisciplinary faculty and guest speaker lineup for its inaugural ZEO Xperience, a three-day

2M ago8K ZEOX

Zeo ScientifiX Launches ZEO Xperience Educational Initiative

The latest announcement is out from Zeo ScientifiX ( ($ZEOX) ). On August 4, 2026, ZEO ScientifiX announced the launch of ZEO Xperience, a three-day immersive educational event for healthcare

3M ago8K ZEOX

Zeo ScientifiX Expands South Florida Regenerative Medicine Presence

An announcement from Zeo ScientifiX ( ($ZEOX) ) is now available. On July 21, 2026, ZEO ScientifiX announced initiatives to strengthen its role in South Florida’s healthcare innovation ecosystem by

3M ago8K ZEOX

ZEOX FAQ

What was Zeo ScientifiX’s price range in the past 12 months?

Zeo ScientifiX lowest stock price was $0.84 and its highest was $2.99 in the past 12 months.

What is Zeo ScientifiX’s market cap?

Zeo ScientifiX’s market cap is $10.66M.

When is Zeo ScientifiX’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

Is Zeo ScientifiX overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Zeo ScientifiX pay dividends?

Zeo ScientifiX does not currently pay dividends.

What is Zeo ScientifiX’s EPS estimate?

Zeo ScientifiX’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Zeo ScientifiX have?

Zeo ScientifiX has 7,837,441 shares outstanding.

Which hedge fund is a major shareholder of Zeo ScientifiX?

Currently, no hedge funds are holding shares in ZEOX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Zeo ScientifiX

Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.

Technical Analysis

Overall Consensus

Indicator	Bullish	Neutral	Bearish
Overall Consensus	10	6	6
Technical Analysis	3	6	1
Moving Averages	7	0	5

Technical Analysis >

Similar Stocks

Stocks similar to ZEOX
Company	Price & Change	Follow
IMNNImunon
XTLBXTL Biopharmaceuticals Sponsored ADR
MRKRMarker Therapeutics
DWTXDogwood Therapeutics
AEONAEON Biopharma

Compare ZEOX Stocks >

Ownership Overview

24.47% Insiders
75.53% Public Companies and Individual Investors

Detailed Ownership Overview >

Popular Stocks

Popular Stocks
Company	Price & Change	Follow
NVDANvidia
AAPLApple
MSFTMicrosoft